The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction

European Heart Journal

Volumn 22, Issue 10, 2001, Pages 837-844

  Sicari, Rosa ^a   Ripoli, A ^a   Picano, E ^a   Borges, A C ^b   Varga, A ^c   Mathias, W ^d   Cortigiani, L ^e   Bigi, R ^f   Heyman, J ^g   Polimeno, S ^h   Silvestri, O ^h   Gimenez, V ⁱ   Caso, P ^j   Severino, S ^j   Djordjevic Dikic, A ^k   Ostojic, M ^k   Baldi, C ^l   Seveso, G ^m   Petix, N ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Hospital Unicor   (Brazil)

^e Ospedale di Lucca   (Italy)

^f Regional Hospital   (Italy)

^g RHO HOSPITAL   (Italy)

^h Caldarelli Hospital   (Italy)

ⁱ Ospedale Monaldi ^*

^j CLINICAL CENTER OF SERBIA   (Serbia)

^k Servizio di Cardiologia   (Italy)

^l Ospedale di Legnano   (Italy)

^m SAN GIUSEPPE HOSPITAL   (Italy)

more..

Author keywords

Dipyridamole stress echocardiography; Myocardial viability; Prognosis; Revascularization

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; CELL VIABILITY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY;

AGED; CHRONIC DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034932006     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2322     Document Type: Article

References (37)

1. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease
2. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
3. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease
4. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
5. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography
6. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease
7. Identification of hibernating myocardium by dobutamine stress echocardiography: Comparison with thallium-201 reinjection imaging
8. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201
9. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization
10. Value of rest Thallium-201 technetium 99m Sestamibi scan and dobutamine echocardiography for detecting myocardial viability
11. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography
12. Low dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization
13. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest
14. Infra-low dose dipyridamole test: A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography
15. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities
16. Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis
17. Combination of dipyridamole and dobutamine during echocardiography improves viability detection: Comparison with thallium scintigraphy
18. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
19. Prognostic value of dipyridamole-echocardiography early after uncomplicated myocardial infarction: A large scale multicenter trial
20. The prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: A dobutamine stress echocardiographic study
21. Dobutamine stress echocardiography for risk stratification following acute myocardial infarction
22. Prognosis of patients with left ventricular dysfunction with and without after myocardial infarction: Relative efficacy of medical therapy and revascularization
23. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3 year mortality with and without revascularization
24. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
25. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
26. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
27. The prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction
28. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
29. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: Results of the GISSI-2 data base
30. Dipyridamole dilates large coronary arteries in conscious dogs
31. Improved outcome after coronary bypass surgery in patients with ischaemic cardimyopathy and residual myocardial viability
32. Prognostic utility of myocardial viability assessment
33. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
34. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: Comparison with stress tahllium imaging
35. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction
36. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
37. The prognostic value of myocardial viability recognized by low dose dobutamine echocardiography in medically treated patients with chronic left ventricular dysfunction